Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiaki Ishigatsubo

Showing results (1-10 of 305) with videos related to

Pageof 31
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 2, 2011
[Behçet's disease from the aspect of autoinflammatory disease]Yoshiaki Ishigatsubo, Sei Samukawa
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritisHaruko Ideguchi, Shigeru Ohno, Yoshiaki Ishigatsubo
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|April 24, 2003
[Clinical assessment of microscopic polyangiitis in elderly patients]Akiko Aoki, Yoshiyuki Kuroiwa, Yoshiaki Ishigatsubo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Tuberculosis associated with anti-TNF therapy]Mitsuhiro Takeno, Shuji Murakami, Yoshiaki Ishigatsubo
Frontiers in Microbiology|September 14, 2013
Pathology of asthmaMakoto Kudo, Yoshiaki Ishigatsubo, Ichiro Aoki
International Journal of Rheumatology|June 16, 2012
Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus ErythematosusRyusuke Yoshimi, Yoshiaki Ishigatsubo, Keiko Ozato
Therapeutics and Clinical Risk Management|May 1, 2015
Adalimumab in the management of Behçet's diseaseAtsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2013
[Chronic myeloid leukemia maintained major molecular response with intermittent dosage of imatinib mesylate]Kazuho Miyashita, Katsumichi Fujimaki, Yoshiaki Ishigatsubo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10]Rika Sakai, Heiwa Kanamori, Yoshiaki Ishigatsubo
Rheumatology International|October 10, 2006
A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infectionHaruko Ideguchi, Shigeru Ohno, Yoshiaki Ishigatsubo
Pageof 31

Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|November 2, 2011
[Behçet's disease from the aspect of autoinflammatory disease]Yoshiaki Ishigatsubo, Sei Samukawa
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritisHaruko Ideguchi, Shigeru Ohno, Yoshiaki Ishigatsubo
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|April 24, 2003
[Clinical assessment of microscopic polyangiitis in elderly patients]Akiko Aoki, Yoshiyuki Kuroiwa, Yoshiaki Ishigatsubo
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 24, 2007
[Tuberculosis associated with anti-TNF therapy]Mitsuhiro Takeno, Shuji Murakami, Yoshiaki Ishigatsubo
Frontiers in Microbiology|September 14, 2013
Pathology of asthmaMakoto Kudo, Yoshiaki Ishigatsubo, Ichiro Aoki
International Journal of Rheumatology|June 16, 2012
Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus ErythematosusRyusuke Yoshimi, Yoshiaki Ishigatsubo, Keiko Ozato
Therapeutics and Clinical Risk Management|May 1, 2015
Adalimumab in the management of Behçet's diseaseAtsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2013
[Chronic myeloid leukemia maintained major molecular response with intermittent dosage of imatinib mesylate]Kazuho Miyashita, Katsumichi Fujimaki, Yoshiaki Ishigatsubo
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Long-term remission after CHOP therapy in a case of multifocal extranodal diffuse large B-cell lymphoma with t(1 ; 14) (p22 ; q32) and rearrangement of bcl-10]Rika Sakai, Heiwa Kanamori, Yoshiaki Ishigatsubo
Rheumatology International|October 10, 2006
A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infectionHaruko Ideguchi, Shigeru Ohno, Yoshiaki Ishigatsubo
Pageof 31